
Global Sleep Symposium Features Inactivators™ Sleep Mask for Performance-Driven Sleep Support as America Faces an Unprecedented Era of Stress
ATLANTA--(BUSINESS WIRE)--Apr 17, 2025--
As April marks National Stress Awareness Month, Atlanta-based sleep performance company The Inactive Company, is showcasing its innovative sleep mask, Inactivators™, as a science-backed solution to help combat stress by promoting deeper, restorative sleep.
Developed over more than a year, largely in collaboration with hospitality and performance brands such as Equinox Hotels, the National Football League, and Collegiate Football properties, The Inactive Company is launching nationally in conjunction with the Global Sleep Symposium. Inactivators feature a patented five-layer design. They are not just sleep masks; they act as a performance tool for anyone looking to enhance their sleep quality, especially during periods of heightened anxiety and stress.
'Stress and sleep are closely interconnected. Each affects the other, and both can be improved with the right tools,' says Lori Oliver, co-founder of The Inactive Company. 'Inactivators are designed to support your sleep physiology, allowing your body to restore, recover, and recharge each night.'
Featuring 100% light blockage, cooling materials, and a customizable ergonomic fit, Inactivators facilitate deeper and more restorative sleep. By tackling common stress-related sleep issues like restlessness and temperature regulation, the mask offers relief for individuals who lie awake with racing thoughts.
'Sleep is essential for everything—memory, mood, immune system,' notes Jill MacRae, co-founder of The Inactive Company. 'This month aims to remind people that managing stress begins with prioritizing rest.'
The five-layer Inactivators mask includes:
More than 60 million Americans suffer from chronic sleep disorders, and only one in three adults gets the recommended 7 to 9 hours of sleep each night. Even mild sleep deprivation can lead to increased stress, cognitive decline, and long-term health risks like high blood pressure and obesity.
Inactivators Take Center Stage at the Global Sleep Symposium
The performance sleep mask will be featured at the second annual Global Sleep Symposium on May 1 in New York City, where sleep experts, wellness leaders, and tech pioneers will gather to explore the future of sleep innovation and technology.
'Our presence at the Symposium is timely. The country and the world are facing unprecedented levels of sleep deprivation. However, as we prepare to hear from some of the brightest minds in health, we feel incredibly optimistic about our Inactivators product and the opportunity to awaken the sleep superpowers inherent in people,' adds Oliver.
About The Inactive Company
The Inactive Company is a sleep performance brand dedicated to developing technology and tools that enhance rest and recovery for everyone. Its innovative sleep mask, Inactivators™, is a scientifically backed solution to improve sleep and is trusted by professional and collegiate sports organizations. By emphasizing the science of sleep and the power of intentional design, the company aims to create a world of well-rested individuals. For more information, visit https://inactiveco.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20250417824043/en/
CONTACT: Jason Gilbreth
[email protected]
(847) 894-8112
KEYWORD: UNITED STATES NORTH AMERICA NEW YORK GEORGIA
INDUSTRY KEYWORD: GENERAL HEALTH MEDICAL DEVICES OTHER HEALTH HEALTH FITNESS & NUTRITION
SOURCE: The Inactive Company
Copyright Business Wire 2025.
PUB: 04/17/2025 09:08 AM/DISC: 04/17/2025 09:08 AM
http://www.businesswire.com/news/home/20250417824043/en
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


WebMD
16 minutes ago
- WebMD
Navigating Skincare: Keloids, Climate, and Consistency
As a child, the dermatologist was the doctor I visited most frequently. Between dark spots on my face, severely chapped lips, and dry skin during the winter, I was always being prescribed a new ointment or remedy to try. Today, the first two issues have been resolved thanks to healthier eating habits and finding the right skin care and lip products for me. However, I still deal with dry skin not only in the winter but throughout most of the year. I've noticed that my keloid scars, along with the surrounding areas, are particularly prone to dry skin. For those unfamiliar with keloids, they're a growth of extra scar tissue that happens where the skin has healed after an injury or surgical procedure. I've been dealing with them since I was in middle school, having developed a large one on the back of my earlobe following my ear piercing. My breast cancer treatment and surgeries introduced several more keloids into my life, including at the site of my chemo port, in the radiated area of my breast, and the largest one – a long scar across my back from one of my breast reconstruction surgeries. While they're not painful, they're often dry, itchy, and hard to reach in certain spots (like the scar on my back, which can be tricky to moisturize properly because of its location). I recently moved from Atlanta to Chicago, which has caused me to rethink my winter skin care routine, especially when it comes to my keloid-prone skin. The cold, dry air makes my scars even itchier and more dehydrated, so I've had to adjust my approach. I've found that layering an oil-based body lotion with a body oil helps my skin lock in moisture longer. Additionally, applying Vaseline to my keloids every morning and night has provided extra relief. My need for a tailored skin care routine isn't just about adapting to the colder months. It's a reminder of how I've had to advocate for my skin's unique needs throughout my health journey – from childhood to my breast cancer treatment. Many aspects of health care don't always consider the needs of people with melanin-rich skin, something I've learned time and time again. One example of this happened before starting radiation, when I was informed that the radiated area would turn darker, like a tan. However, what I experienced was nothing like a cute summer tan – my skin turned completely black and became very tender and painful. I realized early on that the standard skin care recommendations wouldn't work for my skin's needs, requiring me to look for alternatives. Taking proper care of my skin is a constant journey, especially when navigating different climates and changing seasons. I usually shop based on reviews, which has quickly taught me that what works for one person might not work for another, and that's OK. The key is to listen to your body, stay consistent, and adjust your routine to support your skin's unique needs. Whether it's layering oils during the winter or finding products that soothe and hydrate, prioritizing what works best for you is key – your skin will thank you for it.
Yahoo
an hour ago
- Yahoo
International Oncology Experts Meet in Kenya to Address Regional Cancer Needs
National Comprehensive Cancer Network and African Cancer Coalition take part in American Cancer Society Global Academy Regional Workshop to improve cancer care in Sub-Saharan Africa. NAIROBI, Kenya, June 10, 2025 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers in the United States—is joining the African Cancer Coalition (ACC) to update cancer treatment recommendations during the American Cancer Society (ACS) 2025 Global Academy Regional Workshop: Sub-Saharan Africa, in Nairobi, Kenya, June 9-11. The ACS Global Academy Regional Workshop brings together oncology specialists from around the world to improve treatment and support for people with cancer. The three-day workshop includes two days devoted to updating NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) adapted specifically for the Sub-Saharan Africa region. Additional workshops will focus on improving utilization of those guidelines, navigation programs, and provider tools. "The ACS Global Academy Regional Meetings aim to provide a productive and dedicated space for providers to learn from one another, engage in discourse, and reach consensus on regional needs," said Anu Agrawal, MD, Vice President, Global Cancer Support, American Cancer Society. "Continuing the collaboration with ACC and NCCN on the development and update of NCCN Harmonized Guidelines™ provides an essential framework to better understand localized needs and priorities, a key part of this regional meeting in Nairobi." NCCN Guidelines® contain the latest evidence-based, expert consensus-driven recommendations for cancer prevention, screening, treatment, and supportive care. They are the most thorough and frequently updated clinical practice guidelines available in any area of medicine. Approximately half of the two million registered users are from outside the United States, across 190 different countries. The NCCN Global Program oversees adapting and translating the original recommendations to be more accessible for care providers worldwide. During the meeting, the following NCCN Harmonized Guidelines™ for Sub-Saharan will be updated: Anal Carcinoma Biliary Tract Cancers Bladder Cancer Cervical Cancer Colon Cancer Colorectal Cancer Screening Gestational Trophoblastic Neoplasia (GTN) Hepatocellular Carcinoma Kidney Cancer Ovarian Cancer Penile Cancer Rectal Cancer Testicular Cancer Uterine Neoplasms Vulvar Cancer "We have been working in collaboration with experts from ACC across the Sub-Saharan Africa area and ACS for many years to share guidelines that are both aspirational and pragmatic," said Crystal S. Denlinger, MD, Chief Executive Officer, NCCN. "In that time, we have seen improved capacity in cancer-related resources and care, but we have also seen increased cancer rates for the people who live in this region. Our commitment to collaborate with leading experts in the region to maintain and update treatment recommendations, based on the latest research and local circumstances, is more important than ever." Dr. Denlinger is representing NCCN at the meeting, along with Nadeem R. Abu-Rustum, MD, Memorial Sloan Kettering Cancer Center, Chair, NCCN Guidelines Panel for Cervical/Uterine Cancers; Al Benson, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chair, NCCN Guidelines Panels for Colon/Rectal/Anal Cancers and Hepatobiliary Cancers; Thomas Flaig, MD, University of Colorado Cancer Center, Chair, NCCN Guidelines Panel for Bladder/Penile Cancers; Lisa Gurski, PhD, Manager, Licensed Clinical Content, NCCN; Vaishnavi Sambandam, PhD, Oncology Scientist/Medical Writer, NCCN; and Katy Winckworth-Prejsnar, MPH, Director, Global Program, NCCN. Visit to learn more about free resources for improving cancer treatment around the world. About the National Comprehensive Cancer NetworkThe National Comprehensive Cancer Network® (NCCN®) is marking 30 years as a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus-driven recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit for more information. Media Contact: Rachel Darwin267-622-6624darwin@ View original content to download multimedia: SOURCE National Comprehensive Cancer Network Error al recuperar los datos Inicia sesión para acceder a tu cartera de valores Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos Error al recuperar los datos


Business Wire
an hour ago
- Business Wire
Spineology ® Announces the Launch of OptiMesh Align™
ST. PAUL, Minn.--(BUSINESS WIRE)--Spineology Inc., the pioneers of Conform and Expand™ Technology, today announced the launch of its latest innovation, and most advanced patient specific solution yet: OptiMesh Align™ (Align). Built on the proven foundation of OptiMesh ®, Align is uniquely engineered to provide real time, in-situ, independent anterior and posterior implant expansion resulting in a customized, patient specific lordotic shape up to 20 degrees. Align is delivered through one of the smallest insertion profiles available, expanding to one of the largest implant footprints, enabling correction not typically associated with minimally invasive posterior spine approaches. OptiMesh utilizes a biologics-based expansion method, which is designed to overcome limitations and reduce point-loading commonly seen with mechanically expandable implant technology. 'Sagittal alignment is widely considered one of the key correlative indicators to achieving long term clinical success for spine patients. The OptiMesh technology remains the only conforming expandable implant that offers a personalized solution for each patient,' said Brian Snider, Chief Executive Officer. 'With the addition of the lordotic capabilities of the Align implant, our portfolio provides more options to achieve the clinical requirements of surgery.' OptiMesh Align is engineered to produce distraction forces and endplate conformance, provide strength and stability to restore disc height, create a robust fusion scaffold, and now further supports the achievement of alignment objectives. This breakthrough is driven by Spineology's proprietary Conform and Expand flexible mesh interbody technology, setting a new standard for patient specific lumbar interbody fusion. About Spineology Spineology Inc. are the pioneers of Conform and Expand™ technology, a novel development method used in the design of spinal expandable implants. Spineology's core portfolio, OptiMesh ® is the only conforming patient specific spinal implant on the market. OptiMesh is backed with IDE level data which further sets the company apart from traditional fusion procedures. OptiMesh is designed to enable surgeons to support outcomes, and patient recovery while minimizing tissue disruption. With a strong commitment to patient-centered care, Spineology aspires to provide every spine patient the freedom from pain through the creation and delivery of ultra-MIS solutions. For more information about Spineology, visit and follow us on LinkedIn, or Twitter.